A clinical trial designed to show the efficacy of a new drug in reducing progression to hypertension reports the following:
|
New Drug
|
Placebo
|
Total
|
|
Sample size
|
200
|
200
|
400
|
|
Progression to hypertension
|
14%
|
19%
|
33%
|
|
Total
|
200.14
|
200.19
|
400.33
|
Compute the relative risk of progression to hypertension among patients receiving the new drug as compared to the placebo. Explain what this calculated value means concretely.Compute the odds ratio of progression to hypertension among patients receiving the new drug as compared to the placebo.